AURINIA PHARMACEUTICALS INC's ticker is AUPH and the CUSIP is 05156V102. A total of 128 filers reported holding AURINIA PHARMACEUTICALS INC in Q1 2020. The put-call ratio across all filers is 1.03 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $422,711 | -86.4% | 54,403 | -83.0% | 0.01% | -86.4% |
| Q2 2023 | $3,097,774 | +52.4% | 320,018 | +72.6% | 0.08% | +44.6% |
| Q1 2023 | $2,032,444 | +380.9% | 185,442 | +89.6% | 0.06% | +366.7% |
| Q4 2022 | $422,600 | -45.4% | 97,824 | -5.0% | 0.01% | -55.6% |
| Q3 2022 | $774,000 | +75.5% | 102,932 | +134.6% | 0.03% | +35.0% |
| Q2 2022 | $441,000 | -9.1% | 43,871 | +106.8% | 0.02% | -33.3% |
| Q4 2021 | $485,000 | +44.3% | 21,210 | -18.3% | 0.03% | +7.1% |
| Q2 2021 | $336,000 | -27.4% | 25,960 | -27.2% | 0.03% | -33.3% |
| Q1 2021 | $463,000 | +64.8% | 35,648 | +86.8% | 0.04% | +133.3% |
| Q3 2020 | $281,000 | -79.1% | 19,081 | -71.2% | 0.02% | -77.2% |
| Q4 2019 | $1,343,000 | – | 66,304 | – | 0.08% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HealthInvest Partners AB | 230,000 | $993,600 | 1.92% |
| AlphaCentric Advisors LLC | 352,500 | $1,522,800 | 1.50% |
| NEA Management Company, LLC | 3,969,834 | $17,149,683 | 0.96% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 573,530 | $2,477,650 | 0.76% |
| ARMISTICE CAPITAL, LLC | 5,000,000 | $21,600,000 | 0.38% |
| IRONWOOD INVESTMENT MANAGEMENT LLC | 93,658 | $404,603 | 0.27% |
| Artal Group S.A. | 1,000,000 | $4,320 | 0.24% |
| Virtus ETF Advisers LLC | 64,786 | $279,876 | 0.15% |
| TANG CAPITAL MANAGEMENT LLC | 200,000 | $864,000 | 0.13% |
| HighMark Wealth Management LLC | 37,499 | $161,996 | 0.12% |